Medicine-based evidence: the case of antidepressants in patients with coronary artery disease

C Barbui1, G Ostuzzi1

  • 1Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry,University of Verona,Verona,Italy.

Insights

Evidence on antidepressant use in cardiac patients with depression is limited. A study found antidepressants reduced depressive symptoms but were linked to worse cardiovascular outcomes in these patients.

Area of Science:

  • Cardiology
  • Psychiatry
  • Clinical Research

Background:

  • Coronary artery disease (CAD) patients often experience depressive symptoms, impacting treatment and outcomes.
  • Limited evidence exists regarding the dual effects of antidepressants in this population.
  • Real-world data on antidepressant use in cardiac rehabilitation is scarce.

Purpose of the Study:

  • To examine depressive symptoms and antidepressant treatments in cardiac patients within a real-world setting.
  • To investigate the association between antidepressant use and cardiovascular outcomes in CAD patients.
  • To discuss the clinical implications of these findings for patient care and future research.

Main Methods:

  • Retrospective analysis of cardiac patients entering a cardiac rehabilitation program.
  • Description of depressive symptoms and antidepressant treatments utilized.
  • Correlation analysis between antidepressant use and cardiovascular outcomes.

Main Results:

  • Antidepressant use was associated with a reduction in depressive symptoms.
  • Antidepressant use was also linked to poorer cardiovascular outcomes.
  • The study highlights a complex relationship requiring further investigation.

Conclusions:

  • Antidepressant therapy in CAD patients with depression presents a complex risk-benefit profile.
  • Clinical practice should carefully consider potential cardiovascular risks alongside mental health benefits.
  • Further research is needed to optimize antidepressant strategies for cardiac patients.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
283
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
391
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
The Evidence for Evolution02:55

The Evidence for Evolution

Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.3K